Global Veterinary Regenerative Medicine Market Research Report by Animal Type (Small Animals, Large Animals), by Product (Stem Cells, Others) by Application (Orthopedics, Trauma/Wound Care, Others), by End-use (Veterinary Hospitals/Clinics, Veterinary Research Institutes), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19.
Global Veterinary Regenerative Medicine Market
The global Veterinary Regenerative Medicine market was valued at USD 276 million in 2021 which expected to reach USD 610.16 million by 2027 at a CAGR 13.86 % from 2022-2027.
The use of regenerative medicine therapy to treat a range of illness issues has become more widespread in both human and veterinary medicine. In the quickly emerging field of veterinary regenerative medicine, cells and tissues are used in animals in the hopes of repairing diseased or damaged tissues or organs. These materials may include living cells, serum, or bone. Many orthopedics conditions in companion animals, such as osteoarthritis and soft tissue injuries, can be effectively managed with it, according to recent studies. 
Market Drivers
The incidence of acute and chronic disorders in pets, rising pet expenses, regenerative medicine research and development, and key companies' endeavours are among the elements driving the rise. For instance, to improve its stem cell capabilities in veterinary medicine, Boehringer Ingelheim bought Global Stem Cell Technologies (GST), a Belgian veterinary biotech business, in July 2020.
Impact of COVID-19 
The COVID-19 pandemic had a significant impact on the market, resulting in limited availability to veterinary treatment, an increase in pet adoption, supply chain issues, operational challenges, and depressed demand. These issues were worsened by macroeconomic headwinds in 2022, which impacted market growth throughout the year and into Q1 2023. Despite an increase in product prices, Bodevet halted the distribution of its StablePlate RX product for dogs, claiming unfavorable market conditions and a lack of commercial viability.
Market Segmentation
The Global Veterinary Regenerative Medicine Market is segmented into Animal Type, Product Application, and End-use. Based on the Application, the market is segmented into Orthopedics, Trauma/Wound Care, Others. Further, market is segmented into The End-use, the market is segmented into Veterinary Hospitals/Clinics, Veterinary Research Institutes. By Product, the market is segmented into Stem Cells, Others. By Animal Type, the market segmented into Small Animals, Large Animals.
Regional Analysis
Global Veterinary Regenerative Medicine Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America led the market, accounting for the largest share of revenue. This is due to increased knowledge of the benefits of regeneration therapy as well as the existence of major companies. For example, prominent market participants such as Zoetis, VetStem, Vetherapy, Vetbiologics, and others are headquartered in the United States and pursue a variety of revenue-boosting strategies. This contributes to the company's large market share. The Asia Pacific region is expected to develop at the quickest CAGR of over throughout the forecast period, owing to the growing number of facilities offering regenerative medicine services and the region's burgeoning pet population.
Key Players
Various key players are listed in this report such as Boehringer Ingelheim International GmbH, Zoetis, Dechra, ACell Inc., Vetherapy, VetStem, Inc., Ardent, Enso Discoveries, Animal Cell Therapies, Inc, Vetbiologics.
Market Taxonomy
By Animal Type
• Small Animals
• Large Animals
By Product
• Stem Cells
• Others
By Application
• Orthopedics
• Trauma/Wound Care
• Others 
By End-use
• Veterinary Hospitals/Clinics
• Veterinary Research Institutes
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Veterinary Regenerative Medicine Market?
• What will be the growth rate from 2022 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?

Global Veterinary Regenerative Medicine Market 
1 Introduction 
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Veterinary Regenerative Medicine Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Veterinary Regenerative Medicine Market, By Animal Type
5.1 Y-o-Y Growth Comparison, By Animal Type 
5.2 Global Veterinary Regenerative Medicine Market Share Analysis, By Animal Type 
5.3 Global Veterinary Regenerative Medicine Market Size and Forecast, By Animal Type
5.3.1 Small Animals
5.3.2 Large Animals 
6 Global Veterinary Regenerative Medicine Market, By Product
6.1 Y-o-Y Growth Comparison, By Product
6.2 Global Veterinary Regenerative Medicine Market Share Analysis, By Product
6.3 Global Veterinary Regenerative Medicine Market Size and Forecast, By Product
6.3.1 Stem Cells
6.3.2 Others
7 Global Veterinary Regenerative Medicine Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Veterinary Regenerative Medicine Market Share Analysis, By Application
7.3 Global Veterinary Regenerative Medicine Market Size and Forecast, By Application
7.3.1 Orthopedics
7.3.2 Trauma/Wound Care
7.3.3 Others
8 Global Veterinary Regenerative Medicine Market, By End-use 
8.1 Y-O-Y Growth Comparison, By End-use
8.2 Global Veterinary Regenerative Medicine Market Share Analysis, By End-use
8.3 Global Veterinary Regenerative Medicine Market Size and Forecast, By End-use
8.3.1 Veterinary Hospitals/Clinics
8.3.2 Veterinary Research Institutes
9 Global Veterinary Regenerative Medicine Market, By Region
9.1 Global Veterinary Regenerative Medicine Market Share Analysis, By Region
9.2 Global Veterinary Regenerative Medicine Market Share Analysis, By Region
9.3 Global Veterinary Regenerative Medicine Market Size and Forecast, By Region
10 North America Veterinary Regenerative Medicine Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 North America Veterinary Regenerative Medicine Market Share Analysis, By Animal Type
10.3 North America Veterinary Regenerative Medicine Market Size and Forecast, By Product
10.4 North America Veterinary Regenerative Medicine Market Size and Forecast, By Application
10.5 North America Veterinary Regenerative Medicine Market Size and Forecast, By End-use
10.6 North America Veterinary Regenerative Medicine Market Size and Forecast, By Country
10.7.1 U.S.
10.7.2 Canada
10.7.3 Mexico
11 Europe Veterinary Regenerative Medicine Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Europe Veterinary Regenerative Medicine Market Share Analysis, By Animal Type 
11.3 Europe Veterinary Regenerative Medicine Market Size and Forecast, By Product 
11.4 Europe Veterinary Regenerative Medicine Market Size and Forecast, By Application
11.5 Europe Veterinary Regenerative Medicine Market Size and Forecast, By End-use
11.6 Europe Veterinary Regenerative Medicine Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.6.4. Rest of Europe
12 Asia Pacific Veterinary Regenerative Medicine Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Asia Pacific Veterinary Regenerative Medicine Market Share Analysis, By Animal Type 
12.3 Asia Pacific Veterinary Regenerative Medicine Market Size and Forecast, By Product 
12.4 Asia Pacific Veterinary Regenerative Medicine Market Size and Forecast, By Application
12.5 Asia Pacific Veterinary Regenerative Medicine Market Size and Forecast, By End-use
12.6 Asia Pacific Veterinary Regenerative Medicine Market Size and Forecast, By Country
12.6.1 China 
12.7.2 Japan
12.8.3 India
12.9.4. Rest of Asia Pacific
13 Latin America Veterinary Regenerative Medicine Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Latin America Veterinary Regenerative Medicine Market Share Analysis, By Animal Type 
13.3 Latin America Veterinary Regenerative Medicine Market Size and Forecast, By Product 
13.4 Latin America Veterinary Regenerative Medicine Market Size and Forecast, By Application
13.5 Latin America Veterinary Regenerative Medicine Market Size and Forecast, By End-use
13.6 Latin America Veterinary Regenerative Medicine Market Size and Forecast, Country
13.7.1. Brazil
13.8.2. Rest of Latin America
14 Middle East Veterinary Regenerative Medicine Market Analysis and Forecast (2022-2027)
14.1 Introduction
14.2 Middle East Veterinary Regenerative Medicine Market Share Analysis, By Animal Type 
14.3 Middle East Veterinary Regenerative Medicine Market Size and Forecast, By Product 
14.4 Middle East Veterinary Regenerative Medicine Market Size and Forecast, By Application
14.5 Middle East Veterinary Regenerative Medicine Market Size and Forecast, By End-use
14.6 Middle East Veterinary Regenerative Medicine Market Size and Forecast, By Country
14.7.1. Saudi Arabia
14.8.2. UAE
14.9.3. Egypt
14.10.4. Kuwait
14.11.5. South Africa
15Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 Boehringer Ingelheim International GmbH
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2. Zoetis
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3. Dechra
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 ACell Inc.
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Vetherapy
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 VetStem, Inc.
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Ardent
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies 
16.8 Enso Discoveries
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 Animal Cell Therapies, Inc
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10 Vetbiologics
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies